Literature DB >> 8075873

Competitive and non-competitive effects of 5-hydroxyindole on 5-HT3 receptors in N1E-115 neuroblastoma cells.

A R Kooyman1, J A van Hooft, P M Vanderheijden, H P Vijverberg.   

Abstract

1. Effects of 5-hydroxyindole (5-OH-indole) (the aromatic moiety of 5-hydroxytryptamine (5-HT)) on 5-HT-evoked ion current and the nature of these effects on 5-HT3 receptors have been investigated in whole-cell voltage clamp and radioligand binding experiments on cultured N1E-115 mouse neuroblastoma cells. 2. The amplitude of 10 microM 5-HT-evoked ion currents was enhanced up to 150% of the control value by increasing concentrations up to 10 mM 5-OH-indole with half maximum effect of 0.8 mM. At concentrations between 10 mM and 50 mM, 5-OH-indole blocked the 5-HT-evoked ion current. Both the enhancement and the block by 5-OH-indole were accompanied by a marked slowing of the kinetics of decay of the 5-HT-evoked inward currents. 3. The blocking effect was surmounted when the 5-HT concentration was raised from 10 microM to 100 microM. Conversely, the increase in amplitude and the slowing of the decay of the 5-HT-evoked ion current induced by 1 mM 5-OH-indole were not reversed by the same increase of 5-HT concentration. 4. The binding of the selective antagonist [3H]-GR65630 to 5-HT3 receptors was displaced by 5-OH-indole in a concentration-dependent manner with a pKi of 1.96. In saturation binding experiments 10 mM 5-OH-indole reduced the affinity of [3H]-GR65630, whereas the total number of binding sites remained unaffected. 5. It is concluded that the blocking effect of high concentrations of 5-OH-indole is due to a competitive interaction with the antagonist recognition sites of 5-HT3 receptors, whereas the potentiating effect of lower concentrations of 5-OH-indole appears to be mediated by a distinct non-competitive interaction.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8075873      PMCID: PMC1910346          DOI: 10.1111/j.1476-5381.1994.tb13107.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  20 in total

1.  Characterization of 5-HT3 receptors in intact N1E-115 neuroblastoma cells.

Authors:  S C Lummis; G J Kilpatrick; I L Martin
Journal:  Eur J Pharmacol       Date:  1990-09-18       Impact factor: 4.432

2.  Activation and desensitization of the 5-HT3 receptor in a rat glioma x mouse neuroblastoma hybrid cell.

Authors:  J L Yakel; X M Shao; M B Jackson
Journal:  J Physiol       Date:  1991-05       Impact factor: 5.182

3.  Kinetics of the membrane current mediated by serotonin 5-HT3 receptors in cultured mouse neuroblastoma cells.

Authors:  H C Neijt; J J Plomp; H P Vijverberg
Journal:  J Physiol       Date:  1989-04       Impact factor: 5.182

4.  Ethanol potentiation of 5-HT3 receptor-mediated ion current in NCB-20 neuroblastoma cells.

Authors:  D M Lovinger
Journal:  Neurosci Lett       Date:  1991-01-14       Impact factor: 3.046

5.  Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel.

Authors:  A V Maricq; A S Peterson; A J Brake; R M Myers; D Julius
Journal:  Science       Date:  1991-10-18       Impact factor: 47.728

6.  Binding of the 5-HT3 ligand, [3H]GR65630, to rat area postrema, vagus nerve and the brains of several species.

Authors:  G J Kilpatrick; B J Jones; M B Tyers
Journal:  Eur J Pharmacol       Date:  1989-01-10       Impact factor: 4.432

7.  5-Hydroxyindole slows desensitization of the 5-HT3 receptor-mediated ion current in N1E-115 neuroblastoma cells.

Authors:  A R Kooyman; J A van Hooft; H P Vijverberg
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

8.  Trichloroethanol potentiation of 5-hydroxytryptamine3 receptor-mediated ion current in nodose ganglion neurons from the adult rat.

Authors:  D M Lovinger; Q Zhou
Journal:  J Pharmacol Exp Ther       Date:  1993-05       Impact factor: 4.030

9.  Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding.

Authors:  N A Sharif; E H Wong; D N Loury; E Stefanich; A D Michel; R M Eglen; R L Whiting
Journal:  Br J Pharmacol       Date:  1991-04       Impact factor: 8.739

10.  Ion permeation through 5-hydroxytryptamine-gated channels in neuroblastoma N18 cells.

Authors:  J Yang
Journal:  J Gen Physiol       Date:  1990-12       Impact factor: 4.086

View more
  10 in total

1.  Co-expression of the 5-HT3B serotonin receptor subunit alters the biophysics of the 5-HT3 receptor.

Authors:  G Hapfelmeier; C Tredt; R Haseneder; W Zieglgänsberger; B Eisensamer; R Rupprecht; G Rammes
Journal:  Biophys J       Date:  2003-03       Impact factor: 4.033

2.  5-hydroxyindole causes convulsions and increases transmitter release in the CA1 region of the rat hippocampus.

Authors:  Guido Mannaioni; Raffaella Carpenedo; Flavio Moroni
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

3.  Diltiazem causes open channel block of recombinant 5-HT3 receptors.

Authors:  M J Gunthorpe; S C Lummis
Journal:  J Physiol       Date:  1999-09-15       Impact factor: 5.182

4.  The interaction of trichloroethanol with murine recombinant 5-HT3 receptors.

Authors:  D L Downie; A G Hope; D Belelli; J J Lambert; J A Peters; K R Bentley; L J Steward; C Y Chen; N M Barnes
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

5.  Selection of distinct conformational states of the 5-HT3 receptor by full and partial agonists.

Authors:  J A van Hooft; H P Vijverberg
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

6.  5-Chloroindole: a potent allosteric modulator of the 5-HT₃ receptor.

Authors:  Amy S Newman; Nikolaos Batis; Gillian Grafton; Francesca Caputo; Catherine A Brady; Jeremy J Lambert; John A Peters; John Gordon; Keith L Brain; Andrew D Powell; Nicholas M Barnes
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

7.  Auto-inhibition at a ligand-gated ion channel: a cross-talk between orthosteric and allosteric sites.

Authors:  Xiang-Qun Hu
Journal:  Br J Pharmacol       Date:  2014-11-24       Impact factor: 8.739

8.  The L293 residue in transmembrane domain 2 of the 5-HT3A receptor is a molecular determinant of allosteric modulation by 5-hydroxyindole.

Authors:  Xiang-Qun Hu; David M Lovinger
Journal:  Neuropharmacology       Date:  2008-03-27       Impact factor: 5.250

9.  Gut bacteria-derived 5-hydroxyindole is a potent stimulant of intestinal motility via its action on L-type calcium channels.

Authors:  Barbora Waclawiková; Amber Bullock; Markus Schwalbe; Carmen Aranzamendi; Sieger A Nelemans; Gertjan van Dijk; Sahar El Aidy
Journal:  PLoS Biol       Date:  2021-01-22       Impact factor: 8.029

Review 10.  Discriminating between 5-HT₃A and 5-HT₃AB receptors.

Authors:  A J Thompson; S C R Lummis
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.